Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2025-12-24 @ 2:22 PM
NCT ID:
NCT03316859
Eligibility Criteria:
Inclusion Criteria:
* Scheduled to undergo elective cardiac surgery at Bethesda North TriHealth Hospital
* Admitted to Bethesda North TriHealth Hospital CVICU post-surgery
Exclusion Criteria:
* Medically unstable
* Cognitive deficits that impair the patient's ability to understand the informed consent
* Language barriers
* Patient has a documented diagnosis of one of the following: Crohn's disease; Ulcerative Colitis; History of bowel surgery that will impact absorption of study drug (as deemed by physician); History of small bowel obstruction
* Chronic constipation requiring subject to take one of the following medications on a daily basis prior to time of consent: Linzess, Trulance, Amitza, Senna/Senokot, Colace, Dulcolax, Miralax, Metamucil
* Patients on following medications prior to time of consent: Diltiazem, Verapamil, Amiodarone, Ketoconazole, Clarithromycin/ erythromycin, Antivirals
* Conditions that present an increased risk of bowel perforation (as determined by the physician)
* Pre-existing diagnosis of opioid-induced constipation AND receiving naloxegol as a treatment by their physician
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03316859
Study Brief:
Protocol Section:
NCT03316859